Elias Jabbour
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data(2022)2,479 cited
- → Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:(2006)607 cited
- → Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study(2018)563 cited
- → Ibrutinib and Venetoclax for First-Line Treatment of CLL(2019)495 cited
- → Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia(2006)467 cited
- → Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies(2017)435 cited